Skip to main content


Assistant Scientist

Richard Bruns, PhD, MS, researches economic modeling and cost-benefit analysis as it relates to public health and the prevention and mitigation of global catastrophic biological risks.

Contact Info

621 E. Pratt Street, Suite 210

Research Interests

economic modelling; cost-benefit analysis; emerging biological risks; preparedness
Experiences & Accomplishments
Clemson University
Clemson University
Western Carolina University
Richard is a Senior Scholar at the Johns Hopkins Center for Health Security, working on economic modeling and cost-benefit analysis of a variety of public health topics. Particular research interests are using cost-benefit analysis to make the world’s preparations for pandemics and emerging biological risks as effective as possible; and expanding the use of QALYs to better measure a variety of life states and social conditions, so that cost-benefit analysis can include and properly account for all expected side effects of public policies.

Previously, Richard was a Senior Economist at the Food and Drug Administration, doing cost-benefit modeling of many FDA regulations and actions, including the Intentional Adulteration rule designed to harden food production facilities against terrorist attacks, the PHO GRAS determination aka ‘trans fat ban’, and a variety of other rules relating to food and medical devices. Richard also did preliminary modeling on FDA’s upcoming Nicotine Product Standard, a de facto ban on cigarettes that would cause many significant effects on public health and safety, as well as research to quantify and monetize the marginal per-unit effects of a variety of food contaminants, such as mycological toxins and arsenic in rice.
Select Publications
Recent works include:
  • National Strategy for Improving Indoor Air Quality
  • The COVID-19 Nursing Workforce Crisis: Implications for National Health Security Health Secur. 2022 May-Jun;20(3):264-269.
  • Weighing the Cost of the Pandemic - Knowing what we know now, how much damage did COVID-19 cause in the United States? Institute for Progress
  • COVID-19 Vaccine Misinformation and Disinformation Costs an Estimated $50 to $300 Million Each Day
  • School Ventilation: A Vital Tool to Reduce COVID-19 Spread